Literature DB >> 28960828

Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016.

Jesús Oliva1, Concepción Delgado-Sanz1, Amparo Larrauri1.   

Abstract

BACKGROUND: Estimating the national burden of influenza disease is challenging. We aimed to estimate the disease burden of seasonal influenza in Spain, at the primary care and hospital level, over the 6 influenza seasons after 2009 pandemic.
METHODS: We used data from the Spanish Influenza Sentinel Surveillance System to estimate weekly influenza rates and the number of influenza-like illness (ILI) and mild confirmed influenza cases (MCIC). From the surveillance of severe hospitalized confirmed influenza cases (SHCIC), we obtained hospitalization rates and total number of SHCIC, intensive care unit (ICU) admissions and deaths in influenza hospitalized patients. We estimated both mild and severe influenza cases, overall, and by age-group (<5, 5-14, 15-64, and ≥65 years).
RESULTS: The highest cumulative rates of MCIC were observed in <15 years (1395-3155 cases/100 000 population in 5-14 years) and the lowest in ≥65 years (141-608 cases/100 000 population). SHCIC rates revealed a characteristic U-shaped distribution, with annual average hospitalization rates of 16.5 and 18.9 SHCIC/100, 000 p in 0-4 years, and ≥65 years, respectively. We estimated an annual average of 866 868 cases of ILI attended in primary care (55% were MCIC), 3616 SHCIC, 1232 ICU admissions, and 437 deaths in SHCIC. The percentage of ICU admission among SHCIC was highest at 15-64 years (42%), while the hospitalization fatality rate ranged from 1% in 0-4 years to 18% in ≥65 years.
CONCLUSIONS: The ongoing Spanish Influenza Surveillance System allowed obtaining crucial information regarding the impact of mild and severe influenza in Spain.
© 2017 The Authors. Influenza and Other Respiratory Viruses. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Spain; burden disease; influenza; primary care; secondary care; surveillance

Mesh:

Year:  2017        PMID: 28960828      PMCID: PMC5818358          DOI: 10.1111/irv.12499

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


INTRODUCTION

Seasonal influenza is an acute respiratory infection caused by worldwide circulating influenza viruses. The spectrum of disease severity ranges from mild forms of disease to those with severe complications, including death. The main aim of influenza immunization programs is the reduction of hospitalization and death occurring mainly among high‐risk individuals. However, the burden of mild outpatient illness is also important because it accounts for a large proportion of absenteeism in both healthy adults and children.1 Current estimates indicate that, worldwide, the annual influenza epidemics affect 5%‐10% of the world's population, resulting in about 3‐5 million cases of severe illness, and about 250 000‐500 000 deaths.1 The European Center for Disease Prevention and Control (ECDC) estimates that nearly 40 000 people in the European Union die prematurely each year due to influenza‐related causes.2 To better assess and plan targeted public health interventions, national estimates of the burden of seasonal influenza are needed to compare between different influenza seasons and pandemics. Estimating the national burden of influenza disease is however challenging. Recently, the WHO issued recommendations toward the use of influenza surveillance data to better estimate the burden of disease at the national level.3 The Spanish Influenza Sentinel Surveillance System (SISSS) is a well‐established and consolidated system that provides timely information on the activity of mild influenza disease in Spain at primary care level since 1996.4, 5 It is based on sentinel physicians reporting clinical influenza‐like illness (ILI) cases and integrates virological data collected in the same population,6 providing an opportunity to calculate the disease burden in primary care. Regarding influenza severity, the surveillance system for severe hospitalized confirmed influenza cases (SHCIC) was established in Spain after the influenza pandemic of 2009, including sentinel hospitals from all Spanish regions. To date, estimates of influenza‐associated disease burden in Spain have been focused on specific age‐groups,7 regional geographical areas,8 or severe disease but have not considered mild influenza disease.9 Our aim was to utilize data obtained by the SISSS and SHCIC on the surveillance of mild and severe disease at the primary and secondary care level to estimate the age related burden of seasonal influenza disease in Spain, in the post‐2009 pandemic period.

METHODS

The Spanish Influenza Sentinel Surveillance System (SISSS)

The SISSS comprises 17 networks of sentinel physicians (general practitioners and pediatricians) in 17 of the 19 Spanish regions, as well as the network‐affiliated laboratories, including the National Influenza Reference Laboratory (National Centre for Microbiology, World Health Organization National Influenza Centre in Madrid). More than 800 sentinel physicians participated each season covering a population under surveillance of around 1 million of physician's catchment area, giving an overall coverage of 2.2% of the total population of the 17 Spanish regions. All the networks complied with a series of requirements as to the minimum population covered (>1%) and representativeness in terms of age, sex, and degree of urbanization.4, 5 Sentinel physicians reported ILI cases detected in their reference populations on a weekly basis, following a definition based on the EU‐ILI case definition.10 For influenza surveillance, they systematically swabbed (nasal or nasopharyngeal) the first 2 ILI patients each week and sent the swabs to the network‐affiliated laboratories for influenza virus detection. The information collected in the SISSS includes data on demographic, clinical and virological characteristics, seasonal vaccination status, chronic conditions, and pregnancy. Data are entered weekly by each regional sentinel network in a web‐based application (http://vgripe.isciii.es/gripe) and analyzed by the National Centre of Epidemiology to provide timely information on the evolving influenza activity in Spanish regions and at the national level. We used data provided by the SISSS for the 2010‐2011 to 2015‐2016 influenza seasons. We calculated the cumulative weekly ILI rates by season, for all ages and by age‐group (0‐4, 5‐14, 15‐64, and >64 years). By extrapolation to the Spanish population we estimated the number of ILI cases by age and season and by applying the corresponding weekly positivity rate, we estimated the number of mild confirmed influenza cases (MCIC). Point estimates and 95% confidence intervals (95% CI) were calculated.

Surveillance of SHCIC

The number of hospitals participating in the surveillance of SHCIC ranged between 181 in the post‐pandemic season 2010‐2011 and 90 in the 2013‐2014 influenza season. The population under surveillance reached 60% of the total Spanish population in the 2010‐2011 season and was maintained around 45% from the 2011‐2012 season onwards. The catchment population in the surveillance of SHCIC was the reference population of each participating hospital in each season, who would be referred to those hospitals for any reason leading to hospitalization. As the Spanish secondary health system provides national public coverage to almost all the Spanish population, the catchment hospital population is completely generalizable nationwide. The system is based on the notification of those laboratory confirmed influenza hospitalized cases in all wards who met the Spanish SHCIC case definition. This case definition includes several severity criteria: “Any case with clinical features compatible with influenza, requiring hospitalization for clinical severity: at least one of the following criteria: pneumonia, septic shock, acute respiratory distress syndrome, multiple organ dysfunction syndrome, or admission to ICU.” Although it was recommended to swab all influenza cases needing to be hospitalized, in the clinical practice, the extent of respiratory swabbing might depend of the hospital physician's discretion. Following swabbing, only those cases that were influenza confirmed and meet the case definition were reported. Data on clinical, epidemiological, and virological information were collected, as well as the patient outcome. In this way, one unique system provides information on all hospitalized patients with severe confirmed influenza infection, including the ICU‐admitted and deceased. We used data obtained from the surveillance of SHCIC for the same study period and age‐groups as in primary care, to calculate the cumulative hospitalization rates as well as the cumulative rates of ICU admission for each season. We used as denominators the population under surveillance in the participating hospitals. These rates were applied to the total Spanish population to estimate the total number of SHCIC and ICU‐admitted patients (including the 95% CI) for the whole country, by season and age‐group. The number of deaths in SHCIC was also extrapolated to the Spanish population to estimate the number of deaths in influenza hospitalized patients in Spain. We used as denominators the Spanish population of the first year of each season (total and by age‐group), obtained from the Spanish National Statistics Institute.11 All estimations were performed using version 14.1 of the statistical analysis software stata (Stata Corp., College Station, TX, USA).

RESULTS

Seasonality of influenza activity in Spain through the Influenza Surveillance Systems in primary and secondary care

Influenza activity in sentinel primary care varied by studied season (Figure 1). The ILI rates at the epidemic peak ranged between 348 ILI cases per 100 000 population, in the 2014‐2015 season, and 195 ILI cases per 100 000 population, in the 2015‐2016 season. There was a predominant circulation of A(H1N1)pdm09 in the 2010‐2011, 2013‐2014 (with co‐circulation of A[H3N2]), and 2015‐2016 season; influenza A(H3N2) predominated in the 2011‐2012, 2013‐2014 (co‐circulating with A[H1N1]pdm09), and 2014‐2015 season. The influenza B predominated in the 2012‐2013 season, although influenza B virus also circulated in a considerable extent following the peak of 2010‐2011, 2014‐2015, and 2015‐2016 influenza seasons. Three epidemics had a usual presentation on time reaching the peak in January (2010‐2011, 2013‐2014, 2014‐2015) and 3 peaked later, toward middle‐end of February (2011‐2012, 2012‐2013, and 2015‐2016).
Figure 1

Primary care. Weekly ILI rates and number of type/subtype influenza virus by season, SISSS, Spain

Primary care. Weekly ILI rates and number of type/subtype influenza virus by season, SISSS, Spain The weekly number of SHCIC, ICU admissions and deaths in influenza hospitalized patients along the 6 studied influenza seasons is shown in Figure 2. The total number of SHCIC ranged from 525 in the 2012‐2013 season to 3101 in the 2015‐2016 season.
Figure 2

Secondary care. Weekly number of severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients, surveillance of SHCIC, Spain

Secondary care. Weekly number of severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients, surveillance of SHCIC, Spain We provide here results at national level. Influenza activity observed at primary and secondary health care in Spain varied by Spanish region and season and was timely reported through the national weekly and annual influenza reports.

Estimated influenza burden disease

ILI cases and MCIC in sentinel primary care

The highest cumulative MCIC rates were observed in children under 15, whereas the lowest in the elderly (65+ aged) (Figure 3). The cumulative MCIC rates varied from 141 to 608 cases per 100 000 population in the elderly, depending on the season, and from 1395 to 3155 cases per 100 000 population in the 5‐ to 14‐year age‐group.
Figure 3

Primary care. Cumulative annual rates of mild confirmed influenza cases by age group, SISSS, Spain

Primary care. Cumulative annual rates of mild confirmed influenza cases by age group, SISSS, Spain The number of ILI cases in Spain in the study period ranged between 792 783 in 2013‐2014 and 984 061 in 2014‐2015 influenza season; approximately 50% of them were MCIC ranging between 431 468 in 2010‐2011 and 580 331 in 2014‐2015 influenza season (Table 1).
Table 1

Influenza‐like illness (ILI) and mild confirmed influenza cases attended in primary care by age‐group. SISSS, Spain, seasons 2010‐2011 to 2015‐2016

SeasonDominant influenza type/subtypeILI casesMild confirmed influenza cases
Number95% CINumber95% CI
All ages
2010/11A(H1N1)2009860 490858 673862 310431 468430 182432 757
2011/12A(H3N2)893 685891 833895 540482 108480 748483 471
2012/13B844 907843 106846 711464 483463 148465 821
2013/14A(H1N1)2009792 783791 039794 530438 519437 222439 819
2014/15A(H3N2)984 061982 118986 007580 331578 839581 826
2015/16A(H1N1)2009825 283823 503827 066450 735449 420452 053
Aged 65+
2010/11A(H1N1)200941 05440 65841 45311 09610 89011 304
2011/12A(H3N2)73 54873 01774 08144 55044 13744 966
2012/13B45 86545 44646 28717 70817 44817 971
2013/14A(H1N1)200954 12153 66654 57926 53226 21426 853
2014/15A(H3N2)88 67388 09089 25951 22850 78551 674
2015/16A(H1N1)200951 94051 49452 38922 07821 78822 371
15‐64 y
2010/11A(H1N1)2009532 282530 853533 714270 056269 038271 076
2011/12A(H3N2)519 805518 393521 220263 827262 821264 836
2012/13B473 313471 966474 663256 924255 931257 919
2013/14A(H1N1)2009520 517519 104521 933296 631295 564297 700
2014/15A(H3N2)578 879577 389580 372329 361328 237330 488
2015/16A(H1N1)2009449 705448 392451 021239 399238 441240 360
5‐14 y
2010/11A(H1N1)2009192 861192 001193 724106 189105 551106 830
2011/12A(H3N2)171 381170 571172 19499 21498 59899 833
2012/13B219 807218 889220 728139 215138 485139 948
2013/14A(H1N1)2009123 587122 899124 27864 91464 41665 415
2014/15A(H3N2)219 132218 215220 051148 999148 243149 758
2015/16A(H1N1)2009198 662197 789199 538120 573119 893121 256
0‐4 y
2010/11A(H1N1)200994 29293 69194 89644 12743 71644 541
2011/12A(H3N2)128 952128 249129 65874 51773 98375 054
2012/13B105 922105 285106 56250 63650 19651 079
2013/14A(H1N1)200994 55893 95695 16350 44250 00350 884
2014/15A(H3N2)97 37796 76697 99150 74450 30351 187
2015/16A(H1N1)2009124 977124 285125 67268 68568 17269 201
Influenza‐like illness (ILI) and mild confirmed influenza cases attended in primary care by age‐group. SISSS, Spain, seasons 2010‐2011 to 2015‐2016 There were differences in the estimated burden of influenza in primary care by age. In elderly, we estimated the highest annual number of MCIC (from 44 550 to 51 228) in the A(H3N2) dominant influenza seasons 2011‐2012 and 2014‐2015, respectively (Table 1). The 5‐ to 14‐year age‐group was most affected in the B season 2012‐2013 (139 215) and also in the A(H3N2) season 2014‐2015 (148 999) and the A(H1N1)pdm09 season 2015‐2016 (120 573 (Table 1). For children less than 5 years old, the annual number of MCIC was highest in the A(H3N2) season 2011‐2012, with 74 517 MCIC.

SHCIC, ICU admissions and influenza deaths in secondary care

Surveillance in secondary care evidenced for all the influenza seasons the highest annual cumulative SHCIC in the extreme age‐groups: 0‐4 and 65+ years old. We estimated between 8 and 30 hospitalizations per 100 000 population for the children up to 4 years old and between 4 and 30 hospitalizations per 100 000 population in the elderly group, depending on the influenza season (Figure 4).
Figure 4

Secondary care. Cumulative annual rates of severe hospitalized confirmed influenza cases by age group, surveillance of SHCIC, Spain

Secondary care. Cumulative annual rates of severe hospitalized confirmed influenza cases by age group, surveillance of SHCIC, Spain In the study period, there was an annual average of 3616 SHCIC (Table 2). On average, the estimated severe hospitalized rates were highest in children under 4 years of age (18.9 SHCIC/100 000 population) and in elderly (16.5 SHCIC/100 000 population). ICU admission rates were also highest in these age‐groups, with 4.9 ICU admissions/100 000 population and 4.5 ICU admissions/100 000 population in children <4 years and in elderly, respectively. There was an annual average of 437 influenza hospitalized deaths. Annual influenza hospitalized rates were highest in the elderly (3 deaths in influenza hospitalized patients/100 000 population) (Table 2).
Table 2

Annual average number and cumulative rates of severe hospitalized confirmed influenza cases, ICU admissions, and deaths in influenza hospitalized patients, Spain, 2010‐2011 to 2015‐2016

Age‐groupSHCICICU admissionsDeaths in influenza hospitalized patients
NRate per 100 000 pop95% CINRate per 100 000 pop95% CINRate per 100 000 pop95% CI
All ages36167.87.5‐8.012322.62.5‐2.84370.90.8‐1.0
Aged 65+140316.515.7‐17.43834.54.1‐5.02543.02.6‐3.4
15‐64 y16515.35.1‐5.67002.32.1‐2.41700.50.4‐0.6
5‐14 y1072.31.9‐2.7330.70.5‐1.030.10.0‐0.2
0‐4 y42618.917.1‐20.81104.94.0‐5.940.20.1‐0.4
Annual average number and cumulative rates of severe hospitalized confirmed influenza cases, ICU admissions, and deaths in influenza hospitalized patients, Spain, 2010‐2011 to 2015‐2016 The number of SHCIC in Spain in the study period ranged between 1221 in the 2012‐2013 and 6694 in the 2015‐2016 season; the number of ICU admissions ranged between 464 in 2011‐2012 and 2312 in 2015‐2016 season; the number of deaths in influenza hospitalized patients ranged between 115 in 2011‐2012 and 760 in 2015‐2016 season (Table 3).
Table 3

Severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients by age‐group, surveillance of SHCIC, Spain, seasons 2010‐2011 to 2015‐2016

SeasonDominant influenza type/subtypeSHCICICU admissionsDeaths in influenza hospitalized patients
Number95% CINumber95% CINumber95% CI
All ages
2010/11A(H1N1)200927512649285610179551081325291362
2011/12A(H3N2)14051332148046442350811595138
2012/13B122111531291472430517126105150
2013/14A(H1N1)2009548353395630187417901961667617720
2014/15A(H3N2)413940144267125111831322629581680
2015/16A(H1N1)2009669465356856231222192408760707816
Aged 65+
2010/11A(H1N1)20094724305171371151629072111
2011/12A(H3N2)546501594189163218735792
2012/13B35231639111696139695487
2013/14A(H1N1)2009205219642143553508601393355434
2014/15A(H3N2)236622722463586540635465424509
2015/16A(H1N1)2009263225322735714663768433393476
15‐64 y
2010/11A(H1N1)2009177716951862762709818226197257
2011/12A(H3N2)371334411159135186352449
2012/13B567521616277245312473563
2013/14A(H1N1)2009282527222931116911031238258227291
2014/15A(H3N2)120511381275506463552143121168
2015/16A(H1N1)2009316030513272132712571400313279350
5‐14 y
2010/11A(H1N1)200910283124261738207
2011/12A(H3N2)655083181128207
2012/13B8568105241536207
2013/14A(H1N1)2009111911343524497314
2014/15A(H3N2)1261051504129565212
2015/16A(H1N1)2009155132181534069207
0‐4 y
2010/11A(H1N1)200940436644595771165212
2011/12A(H3N2)4113724539274113207
2012/13B2101832405441705212
2013/14A(H1N1)2009471429516113931364110
2014/15A(H3N2)379342419104851265212
2015/16A(H1N1)2009683633736204177234207
Severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients by age‐group, surveillance of SHCIC, Spain, seasons 2010‐2011 to 2015‐2016 Regarding the burden of severe influenza disease by age‐group, in influenza seasons with predominant A(H1N1)pdm09 circulation, we estimated the highest number of SHCIC in young adults: 1777, 2825, and 3160, for the 2010‐2011, 2013‐2014, and 2015‐2016 influenza seasons, respectively (Table 3). ICU admissions and deaths in influenza hospitalized patients were also highest in those seasons. In children less than 5 years old, the season 2015‐2016 yielded the highest number of SHCIC and ICU admissions, 683 and 204, respectively. In elderly, we estimated the highest number of deaths in influenza hospitalized patients in the A(H3N2) 2014‐2015 season, accounting for 465 deaths (95%IC: 424‐509) (Table 3). Of the total estimated number of SHCIC and ICU admissions, 46% and 57%, respectively, were in the young adults group, followed by the elderly (39% and 31%). Only 23 deaths in hospitals were estimated for children less than 5 years old, while the majority of deaths occurred in the 65+ age‐group (58%), followed by the 15‐64 age‐group (39%) (Figure 5).
Figure 5

Percentage of severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients by age group, Spain, seasons 2010–11 to 2015–16

Percentage of severe hospitalized confirmed influenza cases, ICU admissions and deaths in influenza hospitalized patients by age group, Spain, seasons 2010–11 to 2015–16 Within the 6 influenza seasons 2010‐2011 to 2015‐2016, the percentage of ICU admission among the SHCIC was highest (42%) in the 15‐64 age‐group, while the hospitalization fatality rate was highest in elderly (18% of deaths among SHCIC) (Table 4). Children 0‐4 and 5‐14 years old experienced a percentage of ICU admission of 31% and 26%, respectively, but the hospitalization fatality rate was very low (1%‐3%) compared to the young adults and elderly (10% and 18%, respectively) (Table 4).
Table 4

Number and percentage of ICU admissions and deaths in influenza hospitalized patients, Spain, 2010‐2011 to 2015‐2016

Age‐groupSHCICICU admissionsDeaths in influenza hospitalized patients
NNPercentage of admission95% CINHospitalization fatality rates95% CI
All ages21 693739034.133.4‐34.7262212.111.7‐12.5
Aged 65+8420229527.326.3‐28.2152318.117.3‐18.9
15‐64 y9905420042.441.4‐43.4102210.39.7‐10.9
5‐14 y64419730.627.0‐34.3203.11.9‐4.7
0‐4 y255866225.924.2‐27.6230.90.5‐1.3
Number and percentage of ICU admissions and deaths in influenza hospitalized patients, Spain, 2010‐2011 to 2015‐2016

DISCUSSION

We estimated the burden of mild and severe seasonal influenza during the post‐2009 pandemic period in Spain, using information from influenza surveillance systems at the primary care and hospital level. The burden of seasonal influenza has been substantial in Spain, with an annual average of 866 868 ILI cases attended in sentinel primary care, of which 55% were influenza confirmed (474 607 MCIC). At the hospital level, we estimated an annual average of 3616 episodes of severe confirmed influenza hospitalizations, 1232 episodes of influenza ICU admissions, and 437 deaths in influenza hospitalized patients. The SISSS and the surveillance of SHCIC are the only nationally systems for ILI patients attended in sentinel primary care and for severe influenza hospitalized patients, representative for the Spanish population, incorporating both epidemiological and virological surveillance. These systems have proved their usefulness to calculate the burden of influenza disease in Spain using routine surveillance data, allowing us to estimate the impact of mild and severe influenza infection in Spain after the 2009 influenza pandemic. Our results indicate that the seasonal influenza burden of both mild and severe influenza disease in Spain is virus‐ and age‐specific, with significant seasonal variation. During the 6 studied influenza seasons, we found that, while children under the age of 15 years have the highest ILI and MCIC rates, the very young (0‐4 years) and the elderly exhibit the highest rates of severe influenza‐associated hospitalizations. This is consistent with previous studies showing that young children and adolescents have the highest rates of medically attended influenza,7, 12, 13, 14 while the highest hospitalization rates for influenza are observed among very young15 and persons aged ≥65 years.16 Previous exposure to influenza viruses, providing a partial immunity to the circulating viruses, and higher vaccine coverage than in other age‐groups,17, 18 could account for the lower ILI rates at the primary care level in the elderly population. In addition, as the elderly have also the highest prevalence of chronic conditions, they would be more prone to complications and hospitalizations, once acquiring the influenza infection, therefore yielding higher hospitalization rates in this population group.19 General primary care practitioners in Spain attended about half a million ILI cases each season in young adults (15‐64 years) and between 40 000 and 90 000 in persons aged ≥65 years old. Pediatricians attended each season about 100 000 ILI cases in children <5 years of age and 200 000 children aged 5‐14 years. We observed a higher burden of mild influenza for all ages groups in the 2014‐2015 season, dominated by the A(H3N2) influenza virus, when the annual cumulative influenza rate was estimated at 2367 ILI cases/100 000 population, the highest rate since the 2009 pandemic, suggesting a high transmissibility of the virus A(H3N2) during 2014‐2015 epidemic.20 In elderly individuals, our findings suggest a higher burden of mild cases in the 2011‐2012 and 2014‐2015 influenza seasons, dominated by A(H3N2), consistent with the high incidence of medically attended illness in this population previously reported by other authors in primary care during the same period.21 During the influenza seasons, where influenza B was predominant (2012‐2013 season) or presented at a late peak of activity (2014‐2015 and 2015‐2016 influenza seasons), we found that the 5‐14 age‐group was considerably more affected compared to other influenza seasons. This finding was also described in other countries in Europe and in Australia.22, 23, 24 In children younger than 5 years, it is more difficult to find a virus‐specific pattern regarding the influenza disease burden. We found a high disease burden in seasons dominated by A(H1N1) (2015‐2016), but also in A(H3N2) dominant as the 2011‐2012 influenza season. This larger burden in very young children was also reported in many countries in Europe during the 2011‐2012 season, in accordance with a limited immunity against A(H3N2) virus, especially in younger age‐groups, after several influenza seasons without circulation of this influenza virus.25 We have estimated the burden of severe influenza during each influenza epidemic finding an average of 3616 SHCIC, 1232 ICU admissions, and 437 deaths in severe influenza hospitalized patients. The impact of severe influenza varied by age‐group and across the 6 studied influenza seasons. As we mentioned above, the impact of severe influenza during the 6 studied influenza seasons, as measured by the cumulative hospitalization rate, was higher in Spain for children less than 5 years old and elderly. However, in terms of the number of severe influenza cases, young adults bore the largest burden of influenza hospitalization and ICU admission, followed by the elderly. These 2 groups accounted for 85% and almost 90% of the total number of SHCIC and patients admitted to ICU, respectively. Mortality was highest in the elderly with 58% of the deaths reported in influenza hospitalized patients, followed by 39% in young adults. Future studies are needed to explore if certain risk factors contribute to mortality in the young adults group (e.g, underlying conditions). Overall, during the post‐2009 influenza pandemic period, the proportion of severe influenza cases admitted to the UCI was highest in young adults 15‐64 years old, consistent with other studies in the same period.26 In addition, the number of patients in this age‐group admitted to the ICU was higher in A(H1N1)pdm09 dominant seasons compared with other subtype seasons.26, 27 Children under 5 years of age experienced the highest number of SHCIC and ICU admissions during the season 2015‐2016, concordant with the high burden of mild disease in this age‐group observed in primary care in the 2015‐2016 season.28 However, there was no increase in the number of deaths in influenza hospitalized patients belonging to this age‐group. In our study, influenza‐associated mortality increased with age, with the elderly having the highest hospitalization fatality rate, similarly to regression results describing the acute respiratory illness deaths attributable to influenza.15, 29 Consistently, we found the highest number of deaths in influenza hospitalized patients occurred in the elderly group in almost all seasons except the first post‐pandemic 2010‐2011 season. This was the only season when the number of deaths in severe influenza hospitalized patients in young adults was higher than in elderly. Moreover, higher numbers of deaths were observed in the young adults population in each season with important A(H1N1)pdm09 circulation, compared to other seasons. This is in line with the previously documented higher proportions of deaths among patients younger than 65 during the decade following each previous pandemic.30 The highest number of deaths in severe influenza hospitalized patients in the elderly was found in the 2014‐2015 influenza season dominated by A(H3N2), although high numbers of deaths were also observed for this age‐group in the preceding and subsequent A(H1N1)pdm09 seasons. It is accepted that influenza A(H3N2) can cause a relatively higher impact than other influenza viruses, mainly regarding the mortality within older age‐groups.29, 31 Interestingly, this was not reproduced in our study during the 2011‐2012 influenza season, dominated by A(H3N2) circulation. Some contributing factors might be related with limitations of the severe influenza surveillance in Spain, as we describe next. The variation of the impact of severe influenza by season, for all age‐groups, is greater than that observed for mild disease. One of the reasons can be related with seasonal differences in influenza severity and/or the shorter time since the implementation of the surveillance system for SHCIC, but some other factors might have also influenced the findings. After the post‐pandemic 2010‐2011 influenza season, the perception of influenza threat and awareness of the hospital clinics contributing to the severe influenza surveillance, after more than 2 years with exhaustive work load due to “pandemic 2009”, might contribute to under‐notification of SHCIC which influenced the reported severe influenza burden in the 2011‐2012 and 2012‐2013 seasons. However, shortly before the peak of the 2013‐2014 epidemic, a local alert on severe influenza generated a huge media movement in Spain that changed the dynamic of the surveillance and increased the clinical awareness and therefore the recruitment and report of severe influenza cases to the system.32 Although we did not attempt to correct surveillance data for under‐detection, as other studies have carried out,33 the surveillance indicators did evidence an improvement in the SHCIC information reporting, assuming the consolidation of the system from the 2013‐2014 influenza season onwards. Thus, under‐ascertainment of SHCIC within the system may have occurred specially during the 2 seasons following the post‐pandemic 2010‐2011 influenza season, while a higher and more homogenous estimate of burden of severe influenza is found in this study for the last 3 studied seasons.28, 34 Several other limitations must be taken into account when interpreting our study results. Our estimation of severe influenza burden in Spain is restricted to surveillance data which includes severity criteria in the SHCIC case definition. Therefore, our results are conservative when compared to those based on the reporting of influenza hospitalized cases independently of its clinical severity,35 yielding lower hospitalization rates. This also applies to the number of deaths reported in influenza hospitalized patients. Results of regression models, previously applied in our group, gave an estimate of all causes excess mortality rate attributable to influenza of 170 deaths/100 000 population in the >64 age‐group for the 2011‐2012 influenza season.36 In contrast, during the 2011‐2012 influenza season, we registered 73 deaths in influenza hospitalized patients older than 64 years, yielding a rate of 1 death/100 000 population. Studies on the excess mortality attributable to influenza for the post‐2009 influenza pandemic period are ongoing and might provide additional knowledge regarding the impact of influenza epidemics on the mortality of the population in Spain. A possible additional limitation when estimating the burden of severe disease can be derived from collecting only hospitalized cases and not those who are admitted for less than 24 hours to the emergence room. Likewise, admission to the ICU might be affected by clinical management criteria in the case of very elderly people. Considering together the mentioned limitations, we believe our results underestimate the real burden of severe influenza disease in Spain. Nevertheless, updated influenza burden information will be essential to guide public health policy and control measures. An underestimate of the burden of mild influenza may also have occurred, as the ILI case definition only captures a proportion of all symptomatic cases37 and is less sensitive compared to acute respiratory infection (ARI) case definition. However, the sentinel sample positivity is quite high in Spain compared to other countries and besides other factors this could be related to the high performance of ILI's ascertainment of the sentinel physicians belonging to the SISSS.38 Finally, direct comparisons with equivalent studies are difficult due to differences not only in the estimation methods, but also in the different case definitions used, surveillance protocols, sentinel physicians training, primary, and secondary healthcare systems characteristics, etc. In conclusion, we report a considerable influenza disease burden in Spain, with significant seasonal and age variations. Children less than 15 years old yielded the highest influenza activity in primary care, while influenza hospitalization rates were highest among the very young children and the elderly. Nevertheless, the impact of influenza in the National Health System was mainly concentrated in young adults for mild influenza, and in young adults and elderly for severe influenza disease. Estimates of mild and severe influenza disease burden in Spain will allow understanding the impact of the epidemics, including potential influenza pandemics, helping to guide decisions targeting influenza prevention and control. This information, periodically updated, will also be crucial to estimate the impact of influenza vaccination programs, contributing toward enhanced guidance for the development of long lasting and more efficient influenza vaccines.

CONFLICT OF INTEREST

The authors report no competing interests.
  29 in total

1.  Influenza-related mortality in Spain, 1999-2005.

Authors:  Teresa López-Cuadrado; Salvador de Mateo; Silvia Jiménez-Jorge; Camelia Savulescu; Amparo Larrauri
Journal:  Gac Sanit       Date:  2012-01-28       Impact factor: 2.139

2.  Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain.

Authors:  Rodrigo Jiménez-García; Cristina Rodríguez-Rieiro; Valentín Hernandez-Barrera; Pilar Carrasco Garrido; Ana López de Andres; María D Esteban-Vasallo; Maria Felicitas Domínguez-Berjón; Jenaro Astray-Mochales
Journal:  Vaccine       Date:  2013-11-21       Impact factor: 3.641

3.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

Authors:  L Simonsen; M J Clarke; L B Schonberger; N H Arden; N J Cox; K Fukuda
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

4.  [Excess mortality associated with influenza in Spain in winter 2012].

Authors:  Inmaculada León-Gómez; Concepción Delgado-Sanz; Silvia Jiménez-Jorge; Víctor Flores; Fernando Simón; Diana Gómez-Barroso; Amparo Larrauri; Salvador de Mateo Ontañón
Journal:  Gac Sanit       Date:  2015-03-12       Impact factor: 2.139

5.  Costs associated with influenza-related hospitalization in the elderly.

Authors:  Núria Torner; Encarna Navas; Núria Soldevila; Diana Toledo; Gemma Navarro; Aurea Morillo; Maria José Pérez; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

6.  Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.

Authors:  Sandra S Chaves; Deborah Aragon; Nancy Bennett; Tara Cooper; Tiffany D'Mello; Monica Farley; Brian Fowler; Emily Hancock; Pam Daily Kirley; Ruth Lynfield; Patricia Ryan; William Schaffner; Ruta Sharangpani; Leslie Tengelsen; Ann Thomas; Diana Thurston; Jean Williams; Kimberly Yousey-Hindes; Shelley Zansky; Lyn Finelli
Journal:  J Infect Dis       Date:  2013-07-17       Impact factor: 5.226

7.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies.

Authors:  Fabrice Carrat; Elisabeta Vergu; Neil M Ferguson; Magali Lemaitre; Simon Cauchemez; Steve Leach; Alain-Jacques Valleron
Journal:  Am J Epidemiol       Date:  2008-01-29       Impact factor: 4.897

8.  Model estimates of the burden of outpatient visits attributable to influenza in the United States.

Authors:  Gonçalo Matias; François Haguinet; Roger L Lustig; Laurel Edelman; Gerardo Chowell; Robert J Taylor
Journal:  BMC Infect Dis       Date:  2016-11-07       Impact factor: 3.090

9.  The US Influenza Hospitalization Surveillance Network.

Authors:  Sandra S Chaves; Ruth Lynfield; Mary Lou Lindegren; Joseph Bresee; Lyn Finelli
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

10.  Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016.

Authors:  Jesús Oliva; Concepción Delgado-Sanz; Amparo Larrauri
Journal:  Influenza Other Respir Viruses       Date:  2017-12-15       Impact factor: 4.380

View more
  20 in total

1.  Descriptive study of severe hospitalized cases of laboratory-confirmed influenza during five epidemic seasons (2010-2015).

Authors:  Núria Torner; Ana Martínez; Luca Basile; MMar Mosquera; Andrés Antón; Cristina Rius; M Rosa Sala; Sofia Minguell; Elsa Plasencia; Mónica Carol; Pere Godoy; Núria Follia; Irene Barrabeig; M Angeles Marcos; Tomàs Pumarola; Mireia Jané
Journal:  BMC Res Notes       Date:  2018-04-14

2.  Advances in measuring influenza burden of disease.

Authors:  Vernon J Lee; Zheng Jie Marc Ho; Ee Hui Goh; Harry Campbell; Cheryl Cohen; Vanessa Cozza; Julia Fitzner; Jorge Jara; Anand Krishnan; Joseph Bresee
Journal:  Influenza Other Respir Viruses       Date:  2018-01       Impact factor: 4.380

3.  Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States.

Authors:  Justin D Silverman; Nathaniel Hupert; Alex D Washburne
Journal:  Sci Transl Med       Date:  2020-06-22       Impact factor: 17.956

4.  Burden of medically attended influenza in Norway 2008-2017.

Authors:  Siri Helene Hauge; Inger Johanne Bakken; Birgitte F de Blasio; Siri E Håberg
Journal:  Influenza Other Respir Viruses       Date:  2019-01-13       Impact factor: 4.380

5.  Inpatient hospital fatality related to coding (ICD-9-CM) of the influenza diagnosis in Spain (2009-2015).

Authors:  J M San-Román-Montero; R Gil Prieto; C Gallardo Pino; J Hinojosa Mena; A Zapatero Gaviria; A Gil de Miguel
Journal:  BMC Infect Dis       Date:  2019-08-07       Impact factor: 3.090

6.  Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season.

Authors:  Núria Soldevila; Lesly Acosta; Ana Martínez; Pere Godoy; Núria Torner; Cristina Rius; Mireia Jané; Angela Domínguez
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

7.  Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016.

Authors:  Jesús Oliva; Concepción Delgado-Sanz; Amparo Larrauri
Journal:  Influenza Other Respir Viruses       Date:  2017-12-15       Impact factor: 4.380

Review 8.  Age-Related Morbidity and Mortality among Patients with COVID-19.

Authors:  Seung Ji Kang; Sook In Jung
Journal:  Infect Chemother       Date:  2020-06-12

9.  Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.

Authors:  Clara Mazagatos; Concepción Delgado-Sanz; Jesús Oliva; Alin Gherasim; Amparo Larrauri
Journal:  PLoS One       Date:  2018-08-08       Impact factor: 3.240

10.  The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis.

Authors:  A C Teirlinck; B de Gier; A Meijer; G Donker; M de Lange; C Koppeschaar; W van der Hoek; M E Kretzschmar; S A McDonald
Journal:  Epidemiol Infect       Date:  2018-10-23       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.